|
N
|
219
|
55 (25.11%)
|
66 (30.14%)
|
98 (44.75%)
| |
|
Female age at oocyte retrieval (y)
|
30.21 ± 3.87
|
30.85 ± 4.40
|
30.88 ± 3.85
|
29.41 ± 3.44
|
0.021
|
|
BMI (kg/m2)
|
22.47 ± 2.66
|
22.97 ± 2.59
|
22.84 ± 2.59
|
21.93 ± 2.67
|
0.025
|
|
Infertility duration (y)
|
2.00 (1.00–4.00)
|
2.00 (1.00–4.00)
|
2.00 (1.00–4.00)
|
2.00 (1.00–3.80)
|
0.630
|
|
Infertility type (%)
| | | | |
0.943
|
|
Primary
|
60 (27.40%)
|
16 (29.09%)
|
18 (27.27%)
|
26 (26.53%)
| |
|
Secondary
|
159 (72.60%)
|
39 (70.91%)
|
48 (72.73%)
|
72 (73.47%)
| |
|
Gravidity
|
2.00 (0.00, 3.00)
|
2.00 (0.00, 3.00)
|
2.00 (0.00, 2.00)
|
2.00 (0.00, 2.00)
|
0.277
|
|
Parity, Mean ± SD (Range)
|
0.48 ± 0.71 (0.00–3.00)
|
0.55 ± 0.77 (0.00–3.00)
|
0.48 ± 0.73 (0.00–3.00)
|
0.45 ± 0.66 (0.00–3.00)
|
0.722
|
|
No. of miscarriages
|
1.00 (0.00, 2.00)
|
1.00 (0.00, 2.00)
|
1.00 (0.00, 2.00)
|
1.00 (0.00, 2.00)
|
0.418
|
|
Basal serum FSH (mIU/ml)
|
6.80 ± 1.99
|
6.95 ± 2.82
|
6.98 ± 1.78
|
6.58 ± 1.49
|
0.368
|
|
AMH (ng/ml)
|
3.00 (1.90, 4.50)
|
3.30 (2.10, 5.20)
|
2.70 (1.90, 3.90)
|
3.00 (2.10, 5.00)
|
0.082
|
|
No. of retrieved oocytes
|
16.00 (12.00, 21.00)
|
16.00 (12.00, 21.00)
|
15.50 (12.20, 20.00)
|
17.00 (13.00, 21.80)
|
0.686
|
|
Genetic category (%)
| | | | |
0.548
|
|
Reciprocal translocation
|
118 (53.88%)
|
33 (60.00%)
|
35 (53.03%)
|
50 (51.02%)
| |
|
Robertsonian translocation
|
41 (18.72%)
|
6 (10.91%)
|
14 (21.21%)
|
21 (21.43%)
| |
|
Single gene disorders
|
60 (27.40%)
|
16 (29.09%)
|
17 (25.76%)
|
27 (27.55%)
| |
|
Female age at blastocyst transfer (y)
|
30.49 ± 3.80
|
31.13 ± 4.33
|
31.12 ± 3.76
|
29.71 ± 3.39
|
0.024
|
|
Endometrial thickness on the day of P administration (mm)
|
10.18 ± 1.99
|
11.16 ± 2.00
|
10.20 ± 2.09
|
9.62 ± 1.71
|
< 0.001
|
|
Endometrial thickness at transfer (mm)
|
10.45 ± 2.01
|
9.60 ± 1.68
|
10.20 ± 2.09
|
11.09 ± 1.92
|
< 0.001
|
|
Triple-line endometrial pattern on the day of P administration (%)
| | | | |
0.856
|
|
A
|
196 (89.50%)
|
50 (90.91%)
|
58 (87.88%)
|
88 (89.80%)
| |
|
B
|
23 (10.50%)
|
5 (9.09%)
|
8 (12.12%)
|
10 (10.20%)
| |
|
E2 on the day of P administration (pg/mL)
|
124.20 (83.50, 174.80)
|
127.40 (92.40, 212.00)
|
122.80 (82.20, 155.50)
|
117.70 (80.40, 171.60)
|
0.226
|
|
LH on the day of P administration (mIU/ml)
|
19.30 (12.70, 29.20)
|
20.70 (14.40, 31.10)
|
19.70 (12.20, 31.40)
|
18.10 (12.10, 26.90)
|
0.744
|
|
P on the day of P administration (ng/ml)
|
1.10 (0.90, 1.40)
|
1.10 (0.80, 1.30)
|
1.10 (0.90, 1.40)
|
1.20 (1.00, 1.60)
|
0.094
|
|
Embryo expansion grade at transfer
|
3.42 ± 0.86
|
3.46 ± 0.95
|
3.52 ± 0.95
|
3.33 ± 0.74
|
0.353
|
|
Embryo inner cell mass grade at transfer (%)
| | | | |
0.236
|
|
A
|
15 (6.88%)
|
1 (1.85%)
|
6 (9.09%)
|
8 (8.16%)
| |
|
B
|
203 (93.12%)
|
53 (98.15%)
|
60 (90.91%)
|
90 (91.84%)
| |
|
Embryo trophectoderm grade at transfer (%)
| | | | |
0.699
|
|
A
|
1 (0.46%)
|
0 (0.00%)
|
0 (0.00%)
|
1 (1.02%)
| |
|
B
|
117 (53.67%)
|
26 (48.15%)
|
37 (56.06%)
|
54 (55.10%)
| |
|
C
|
100 (45.87%)
|
28 (51.85%)
|
29 (43.94%)
|
43 (43.88%)
| |
|
Morphology score (%)
| | | | |
0.281
|
|
< 4 BC
|
147 (67.43%)
|
36 (66.67%)
|
40 (60.61%)
|
71 (72.45%)
| |
|
≥ 4 BC
|
71 (32.57%)
|
18 (33.33%)
|
26 (39.39%)
|
27 (27.55%)
| |
|
Day of embryo development at transfer (%)
| | | | |
0.706
|
|
Day 5
|
156 (71.56%)
|
38 (69.09%)
|
49 (75.38%)
|
69 (70.41%)
| |
|
Day 6
|
62 (28.44%)
|
17 (30.91%)
|
16 (24.62%)
|
29 (29.59%)
| |
|
Clinical pregnancy rate (%)
|
131 (59.82%)
|
25 (45.45%)
|
42 (63.64%)
|
64 (65.31%)
|
0.042
|
|
Miscarriage rate (%)
|
21 (16.03%)
|
2 (8.00%)
|
5 (11.90%)
|
14 (21.88%)
|
0.187
|
|
Live-birth rate (%)
|
111 (56.63%)
|
23 (46.94%)
|
37 (64.91%)
|
51 (56.67%)
|
0.177
|
